Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (343)
All Articles published online
|
Publishing Process of This Article
|
Dec 24, 2025 (publication date) through Feb 16, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Calibasi-Kocal G. Inflammatory cytokine-associated cisplatin resistance in non-small cell lung cancer and re-sensitization through interleukin-6 receptor blockade. World J Clin Oncol 2025; 16(12): 114275 [PMID: 41480163 DOI: 10.5306/wjco.v16.i12.114275] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Calibasi-Kocal G. Inflammatory cytokine-associated cisplatin resistance in non-small cell lung cancer and re-sensitization through interleukin-6 receptor blockade. World J Clin Oncol 2025; 16(12): 114275 [PMID: 41480163 DOI: 10.5306/wjco.v16.i12.114275] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i12/114275.htm |
| Number | Citing Articles |
| 1 |
Xinmin Tian, Zhixiong Qiao, Yan Ma, Rui Yang, Yusong Zheng, Wei He, Yabo Xu. Metformin inhibits non-small cell lung cancer via lncRP11-242D8.1. Archives of Biochemistry and Biophysics 2026; 778: 110751 doi: 10.1016/j.abb.2026.110751
|